Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Boston Scientific Corporation
483
•Boston Scientific Corporation•September 1, 2005

Boston Scientific Corporation – FDA 483, Sep 1, 2005

Record Details

The FDA Form 483 inspection revealed multiple deficiencies in the facility's quality system and manufacturing processes.

**Quality System and Audit Deficiencies:** * **Incomplete Audit Procedures:** The CRM Audit Procedure 005014 lacked specific details in the 2005 CAPA Audit Plan, failing to ensure complete coverage of QSR requirements, particularly regarding non-conforming data sources. * **Inadequate Corrective and Preventive Actions (CAPA):** Root cause was not determined for TR 05013 Rev. B 06/22/05 INSIGNIA, concerning "no output" and "fails to deliver therapy" issues. No CAPAs were implemented for design control inputs/process procedures to mitigate Single Event Upsets (SEU) or to change design control. * **Management Responsibility:** Executive management failed to ensure an adequate and effective quality system. The Insignia product, with confirmed "no output" failures since 2003, continued distribution without informing users of the potential failure mode or the identified TR 03030 issue, despite approximately 11 explanted devices due to this problem. * **Inadequate Quality Data Analysis:** Failure data from equipment following processes were not routinely collected or analyzed for process monitoring and control. Non-conforming product images from component mounting equipment were not routinely analyzed for quality non-conformances.

**Process Control and

Company
Boston Scientific Corporation
Inspection date
September 1, 2005
Product type
Devices
Office
Minneapolis District Office
Person
  • Joseph M. Edwin (Import Specialist)
View Company Profile

ID · 6cc05745-9ea0-4532-8ce8-3db85db46bba

Violation Codes10
FD&C Act 801(a)(3)21 CFR 820.198(a)21 CFR 820.100(a)21 CFR 820.30(a)21 CFR 820.2221 CFR 820.80(a)21 CFR 820.75(a)21 CFR 820.30(e)21 CFR 820.70(i)21 CFR 820.70(g)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Boston Scientific Corporation
  • 483 - 2025-04-07April 7, 2025
  • 483 - 2021-11-18November 18, 2021
  • 483 - 2017-09-22September 22, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boston Scientific Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.